← All decks
The first 25 slides, exactly as they appear. The full deck has 53 content slides.
Paediatric Surgery
Injectable Bulking Agents in the Treatment of Pediatric Ur
Built from Puri — Pediatric Surgery and Pediatric Urology
What’s inside
8 sections · 53 slides
The Problem and the Idea
Why children leak, and how a simple injection can help
- Urinary incontinence is a symptom, not one disease
- The unsolved problem: rebuilding the outlet
- What is a bulking agent?
- The promising but flawed early results
- Early promise came with a warning
- How normal continence works, and where injections help
- The mechanism: restoring coaptation
- How an injected bulking agent seals the outlet
- Who actually benefits?
Working Up the Child
Measuring the leak before you treat it
- Quantify the incontinence first
- Imaging and pressure studies
The Other Options
What injections are competing against
- Two problems, fewer sphincter fixes
- Properties of the ideal bulking agent
- A crucial safety rule: protect the kidneys
- Slings and reconstruction: effective but demanding
- The artificial urinary sphincter
Delivering the Agent
Categories, regulation, and the four routes
- How agents are categorised
- Agents currently FDA-approved in the USA
- A regulatory caution
- Four ways to reach the target
- The four routes for injecting the agent
- Transurethral and periurethral routes
- Antegrade routes for the difficult outlet
The Historical Agents
PolyTef and collagen: how the field learned its lessons
- Polytetrafluoroethylene (PolyTef)
- Cross-linked collagen (Contigen): the old standard
- What collagen achieved, and its safety debate
The Modern Agents
What is available and how well each performs
- Polydimethylsiloxane (Macroplastique)
- Macroplastique in children: the results
- Calcium hydroxylapatite (Coaptite)
- Durasphere and Bulkamid
Retired and Experimental Agents
What has been tried, withdrawn, or is still emerging
- Silicone membranes and Bioglass
- Dextranomer/hyaluronan (Deflux, Zuidex)
- Ethylene vinyl copolymer (Uryx, Tegress)
- Autologous therapies: using the patient's own cells
- The frontier: engineered muscle
Where This Leaves Us
Honest limits and cautious optimism
- Conclusion: a useful but imperfect tool
- Read the evidence with healthy skepticism
- Key takeaways
- References (1/5)
- References (2/5)
- References (3/5)
- References (4/5)
- References (5/5)
- Pediatric Surgery and Pediatric Urology